Spire Wealth Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-947
Closed -$15K 2508
2022
Q2
$15K Buy
947
+2
+0.2% +$34 ﹤0.01% 1782
2022
Q1
$15K Buy
945
+3
+0.3% +$38 ﹤0.01% 1904
2021
Q4
$8K Buy
942
+2
+0.2% +$17 ﹤0.01% 2457
2021
Q3
$8K Buy
940
+3
+0.3% +$24 ﹤0.01% 2168
2021
Q2
$9K Buy
937
+1
+0.1% +$8 ﹤0.01% 2163
2021
Q1
$7K Buy
+936
New +$6.6K ﹤0.01% 2538

Other funds holding PTEN

Spire Wealth Management's PTEN Position: Q3 2022 in Review

Spire Wealth Management sold out of Patterson-UTI (PTEN) in Q3 2022, closing a stake of 947 shares — an estimated $15K sold.

Spire Wealth Management first reported a position in PTEN in Q1 2021 and held it in 6 quarters. The position peaked at $15K in Q2 2022. 285 funds tracked by Wall St. Rank hold PTEN as of Q3 2022.

  • Spire Wealth Management reported no remaining Patterson-UTI position as of Q3 2022 after selling out during the quarter.
  • Spire Wealth Management sold 947 Patterson-UTI shares in Q3 2022, an estimated $15K.
  • Spire Wealth Management first reported a position in Patterson-UTI in Q1 2021 and held it in 6 quarters.
  • Spire Wealth Management's Patterson-UTI position peaked at $15K in Q2 2022.
  • 285 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2022.

Based on Spire Wealth Management's 13F filing for Q3 2022, filed 7 Nov 2022.